Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

The association of socioeconomic status with three-year clinical outcomes in patients with acute myocardial infarction who underwent percutaneous coronary intervention.

Kim JH, Jeong MH, Park IH, Choi JS, Rhee JA, Lee DH, Park SH, Kim IS, Jeong HC, Cho JY, Jang SY, Lee KH, Park KH, Sim DS, Kim KH, Hong YJ, Park HW, Kim JH, Ahn Y, Cho JG, Park JC.

J Korean Med Sci. 2014 Apr;29(4):536-43. doi: 10.3346/jkms.2014.29.4.536. Epub 2014 Apr 1.

2.

Characteristics, in-hospital and long-term clinical outcomes of nonagenarian compared with octogenarian acute myocardial infarction patients.

Lee KH, Ahn Y, Kim SS, Rhew SH, Jeong YW, Jang SY, Cho JY, Jeong HC, Park KH, Yoon NS, Sim DS, Yoon HJ, Kim KH, Hong YJ, Park HW, Kim JH, Cho JG, Park JC, Jeong MH, Cho MC, Kim CJ, Kim YJ; KAMIR (Korea Acute Myocardial Infarction Registry) Investigators.

J Korean Med Sci. 2014 Apr;29(4):527-35. doi: 10.3346/jkms.2014.29.4.527. Epub 2014 Apr 1.

3.

Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention.

Jakobsen L, Niemann T, Thorsgaard N, Thuesen L, Lassen JF, Jensen LO, Thayssen P, Ravkilde J, Tilsted HH, Mehnert F, Johnsen SP.

Circ Cardiovasc Interv. 2012 Oct;5(5):641-8. doi: 10.1161/CIRCINTERVENTIONS.112.968271. Epub 2012 Oct 2.

4.

GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry.

Bae EH, Lim SY, Cho KH, Choi JS, Kim CS, Park JW, Ma SK, Jeong MH, Kim SW.

Am J Kidney Dis. 2012 Jun;59(6):795-802. doi: 10.1053/j.ajkd.2012.01.016. Epub 2012 Mar 23.

PMID:
22445708
5.

Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.

Marcucci R, Paniccia R, Antonucci E, Gori AM, Fedi S, Giglioli C, Valente S, Prisco D, Abbate R, Gensini GF.

Am J Cardiol. 2006 Nov 1;98(9):1156-9. Epub 2006 Aug 31.

PMID:
17056317
6.

Prognostic impact of significant non-infarct-related left main coronary artery disease in patients with acute myocardial infarction who receive a culprit-lesion percutaneous coronary intervention.

Seo SM, Kim TH, Kim CJ, Hwang BH, Kang MK, Koh YS, Min J, Chang K, Kim PJ, Park HJ, Chung WS, Jeong MH, Kim YJ, Park SJ, Seung KB; Korean Acute Myocardial Infarction Registry Investigators.

Coron Artery Dis. 2012 Aug;23(5):307-14. doi: 10.1097/MCA.0b013e3283519f25.

PMID:
22527385
7.

Different impact of diabetes mellitus on in-hospital and 1-year mortality in patients with acute myocardial infarction who underwent successful percutaneous coronary intervention: results from the Korean Acute Myocardial Infarction Registry.

Park KH, Ahn Y, Jeong MH, Chae SC, Hur SH, Kim YJ, Seong IW, Chae JK, Hong TJ, Cho MC, Bae JH, Rha SW, Jang YS; Korean Acute Myocardial Infarction Registry Investigators.

Korean J Intern Med. 2012 Jun;27(2):180-8. doi: 10.3904/kjim.2012.27.2.180. Epub 2012 May 31.

8.

Low socioeconomic status increases short-term mortality of acute myocardial infarction despite universal health coverage.

Wang JY, Wang CY, Juang SY, Huang KY, Chou P, Chen CW, Lee CC.

Int J Cardiol. 2014 Mar 1;172(1):82-7. doi: 10.1016/j.ijcard.2013.12.082. Epub 2014 Jan 7.

PMID:
24444479
9.

Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?

Mamas MA, Ratib K, Routledge H, Neyses L, Fraser DG, de Belder M, Ludman PF, Nolan J; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

JACC Cardiovasc Interv. 2013 Jul;6(7):698-706. doi: 10.1016/j.jcin.2013.03.011. Epub 2013 Jun 14.

10.

Sex-specific outcomes of diabetic patients with acute myocardial infarction who have undergone percutaneous coronary intervention: a register linkage study.

Blöndal M, Ainla T, Marandi T, Baburin A, Eha J.

Cardiovasc Diabetol. 2012 Aug 11;11:96. doi: 10.1186/1475-2840-11-96.

11.

Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction.

Harjai KJ, Stone GW, Boura J, Mattos L, Chandra H, Cox D, Grines L, O'Neill W, Grines C; Primary Angioplasty in Myocardial Infarction Investigators.

Am J Cardiol. 2003 May 1;91(9):1041-5.

PMID:
12714143
13.

Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty).

Spaulding C, Teiger E, Commeau P, Varenne O, Bramucci E, Slama M, Beatt K, Tirouvanziam A, Polonski L, Stella PR, Clugston R, Fajadet J, de Boisgelin X, Bode C, Carrié D, Erglis A, Merkely B, Hosten S, Cebrian A, Wang P, Stoll HP, Henry P.

JACC Cardiovasc Interv. 2011 Jan;4(1):14-23. doi: 10.1016/j.jcin.2010.10.007.

14.

Relevance of gender in patients with acute myocardial infarction undergoing coronary interventions.

Ortolani P, Solinas E, Guastaroba P, Marino M, Casella G, Manari A, Piovaccari G, Ottani F, Varani E, Campo G, Marzocchi A, Merlini PA, Caminiti C, De Palma R, Ardissino D.

J Cardiovasc Med (Hagerstown). 2013 Jun;14(6):421-9. doi: 10.2459/JCM.0b013e328357bb04.

PMID:
22914306
15.

Impact of family history on the presentation and clinical outcomes of coronary heart disease: data from the Korea Acute Myocardial Infarction Registry.

Kim C, Chang HJ, Cho I, Sung JM, Choi D, Jeong MH, Jang YS; Korea Acute Myocardial Infarction Registry Investigators.

Korean J Intern Med. 2013 Sep;28(5):547-56. doi: 10.3904/kjim.2013.28.5.547. Epub 2013 Aug 14.

16.

Cardiogenic shock complicating acute myocardial infarction in the elderly: predictors of long-term survival.

Tomassini F, Gagnor A, Migliardi A, Tizzani E, Infantino V, Giolitto S, Conte MR, Lanza GA, Gnavi R, Varbella F.

Catheter Cardiovasc Interv. 2011 Oct 1;78(4):505-11. doi: 10.1002/ccd.22911. Epub 2011 Jan 4.

PMID:
21953748
17.

Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes.

Guptill JT, Mehta RH, Armstrong PW, Horton J, Laskowitz D, James S, Granger CB, Lopes RD.

Circ Cardiovasc Interv. 2013 Apr;6(2):176-83. doi: 10.1161/CIRCINTERVENTIONS.112.000159. Epub 2013 Apr 2.

18.

Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial).

Singh HS, Dangas GD, Guagliumi G, Yu J, Witzenbichler B, Kornowski R, Grines C, Gersh B, Dudek D, Mehran R, Stone GW.

Am J Cardiol. 2012 Oct 1;110(7):940-7. doi: 10.1016/j.amjcard.2012.05.026. Epub 2012 Jun 28.

PMID:
22748356
19.

Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.

Farkouh ME, Reiffel J, Dressler O, Nikolsky E, Parise H, Cristea E, Baran DA, Dizon J, Merab JP, Lansky AJ, Mehran R, Stone GW.

Circ Cardiovasc Interv. 2013 Jun;6(3):216-23. doi: 10.1161/CIRCINTERVENTIONS.112.000142. Epub 2013 May 7.

20.

Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial.

Nikolsky E, Mehran R, Sadeghi HM, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Fahy M, Lansky AJ, Stone GW.

JACC Cardiovasc Interv. 2009 Jul;2(7):624-32. doi: 10.1016/j.jcin.2009.05.004.

Items per page

Supplemental Content

Write to the Help Desk